{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:01:06Z","timestamp":1759334466056,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["Q007"],"award-info":[{"award-number":["Q007"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.imbio.2015.12.002","type":"journal-article","created":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T13:37:39Z","timestamp":1449927459000},"page":"568-576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients"],"prefix":"10.1016","volume":"221","author":[{"given":"Minako","family":"Oshima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Deitiker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Roger","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Zouhair","family":"Atassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2015.12.002_bib0005","series-title":"Scientific and Therapeutic Aspects of Botulinum Toxin","first-page":"103","article-title":"Immunologic and other properties of therapeutic botulinum toxin serotypes","author":"Aoki","year":"2002"},{"key":"10.1016\/j.imbio.2015.12.002_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1984.tb08516.x","article-title":"Antigenic structures of proteins. Their determination has revealed important aspects of immune recognition and generated strategies for synthetic mimicking or protein binding sites","volume":"145","author":"Atassi","year":"1984","journal-title":"Eur. J. Biochem."},{"issue":"Suppl. 8","key":"10.1016\/j.imbio.2015.12.002_bib0015","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1002\/mds.20020","article-title":"Basic immunological aspects of botulinum toxin therapy","volume":"19","author":"Atassi","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.imbio.2015.12.002_bib0020","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/BF01886751","article-title":"Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855\u20131296 with antitoxin antibodies from three host species","volume":"15","author":"Atassi","year":"1996","journal-title":"J. Prot. Chem."},{"key":"10.1016\/j.imbio.2015.12.002_bib0025","first-page":"219","article-title":"Structure, activity, and immune (T and B cell) recognition of botulinum neurotoxins","volume":"19","author":"Atassi","year":"1999","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.imbio.2015.12.002_bib0030","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.molimm.2005.01.016","article-title":"Submolecular recognition profiles in two mouse strains of non-protective and protective antibodies against botulinum neurotoxin A","volume":"42","author":"Atassi","year":"2005","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2015.12.002_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imbio.2011.09.001","article-title":"Antibody and T cell recognition of the light chain of botulinum neurotoxin A in two high-responder mouse strains","volume":"217","author":"Atassi","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2015.12.002_bib0040","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/mds.22157","article-title":"Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay","volume":"23","author":"Brin","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.imbio.2015.12.002_bib0045","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/mds.870120414","article-title":"Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale","volume":"12","author":"Comella","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.imbio.2015.12.002_bib0050","series-title":"Botulinum Neurotoxin and Tetanus Toxin","article-title":"The structure of botulinum neurotoxin","author":"Das Gupta","year":"1989"},{"key":"10.1016\/j.imbio.2015.12.002_bib0055","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.4049\/jimmunol.143.12.3881","article-title":"Processing of tetanus toxin by human antigen-presenting cells: evidence for donor and epitope-specific processing pathways","volume":"143","author":"Demotz","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.12.002_bib0060","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4049\/jimmunol.142.2.394","article-title":"Delineation of several DR-restricted tetanus toxin T cell epitopes","volume":"142","author":"Demotz","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.12.002_bib0065","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/315324","article-title":"Universal epitopes for human CD4+ cells on tetanus and diphtheria toxins","volume":"181","author":"Diethelm-Okita","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imbio.2015.12.002_bib0070","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.molimm.2006.03.011","article-title":"Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT\/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT\/A","volume":"44","author":"Dolimbek","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2015.12.002_bib0075","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1212\/WNL.50.6.1624","article-title":"Mouse bioassay versus Western blot assay for botulinum toxin antibodies: correlation with clinical response","volume":"50","author":"Hanna","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.imbio.2015.12.002_bib0080","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/eji.1830200304","article-title":"Identification of two promiscuous T cell epitopes from tetanus toxin","volume":"20","author":"Ho","year":"1990","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2015.12.002_bib0085","series-title":"Scientific and Therapeutic Aspects of Botulinum Toxin","article-title":"Botulinum toxin: clinical implications of antigenicity and immunoresistance","author":"Jankovic","year":"2002"},{"key":"10.1016\/j.imbio.2015.12.002_bib0090","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S1474-4422(06)70574-9","article-title":"Treatment of dystonia","volume":"5","author":"Jankovic","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.imbio.2015.12.002_bib0095","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.toxicon.2008.11.013","article-title":"Disease-oriented approach to botulinum toxin use","volume":"54","author":"Jankovic","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.imbio.2015.12.002_bib0100","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1212\/01.WNL.0000055087.96356.BB","article-title":"Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia","volume":"60","author":"Jankovic","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.imbio.2015.12.002_bib0105","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1006\/jmbi.1999.2945","article-title":"Sequence homology and structural analysis of the clostridial neurotoxins","volume":"291","author":"Lacy","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.imbio.2015.12.002_bib0110","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1126\/science.130.3378.763","article-title":"The most poisonous poison","volume":"130","author":"Lamanna","year":"1959","journal-title":"Science"},{"key":"10.1016\/j.imbio.2015.12.002_bib0115","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0161-5890(94)90021-3","article-title":"Profile of the regions of acetylcholine receptor \u03b1 chain recognized by T-lymphocytes and by antibodies in EAMG-susceptible and non-susceptible mouse strains after different periods of immunization with the receptor","volume":"31","author":"Oshima","year":"1994","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2015.12.002_bib0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2011.06.005","article-title":"Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patients","volume":"237","author":"Oshima","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2015.12.002_bib0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jneuroim.2011.10.005","article-title":"Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and\/or other movement disorders treated with BoNT\/A or BoNT\/B","volume":"240-24","author":"Oshima","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2015.12.002_bib0130","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.imbio.2014.07.019","article-title":"Regions recognized on the light chain of botulinum neurotoxin type A by T lymphocytes of SJL and BALB\/c mice primed with inactivated toxin","volume":"219","author":"Oshima","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2015.12.002_bib0135","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.4049\/jimmunol.151.11.6175","article-title":"Mapping the major human T helper epitopes of tetanus toxin: the emerging picture","volume":"151","author":"Reece","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.12.002_bib0140","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.4049\/jimmunol.157.7.3192","article-title":"B-cell activation in vitro by helper T cells specific to region \u03b1146-162 of Torpedo californica nicotinic acetylcholine receptor","volume":"157","author":"Rosenberg","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.12.002_bib0145","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/08820139709022704","article-title":"Localization of the regions on the C-terminal domain of the heavy chain of botulinum A recognized by T lymphocytes and by antibodies after immunization of mice with pentavalent toxoid","volume":"26","author":"Rosenberg","year":"1997","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.imbio.2015.12.002_bib0150","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/359832a0","article-title":"Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin","volume":"359","author":"Schiavo","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2015.12.002_bib0155","series-title":"Botulinum Neurotoxin and Tetanus Toxin","article-title":"Peripheral actions of the botulinum toxins","author":"Simpson","year":"1989"},{"key":"10.1016\/j.imbio.2015.12.002_bib0160","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/187153012802002893","article-title":"Evaluation of specific immune responses to BoNT\/A and tetanus toxoid in patients undergoing treatment for neurologic disorders","volume":"12","author":"Vlata","year":"2012","journal-title":"Endocr. Metab. Immune. Disord. Drug Targets"},{"key":"10.1016\/j.imbio.2015.12.002_bib0165","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/aem.58.8.2345-2354.1992","article-title":"Molecular cloning of the Clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence","volume":"58","author":"Whelan","year":"1992","journal-title":"Appl. Environ. Microbiol."},{"year":"1996","series-title":"Biostatistical Analysis","author":"Zar","key":"10.1016\/j.imbio.2015.12.002_bib0170"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298515301030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298515301030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:40:03Z","timestamp":1759250403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298515301030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0171298515301030"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2015.12.002","relation":{},"ISSN":["0171-2985"],"issn-type":[{"type":"print","value":"0171-2985"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2015.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}